TAO LI

Dr. TAO LI


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Aging Medicine
Verified
Journal Article
Open access
PDF file
CWChuyao Wang
Chuyao Wang
BCBangwei Chen
Bangwei Chen
QFQian Feng
Qian Feng
CNChao Nie
Chao Nie
TLTAO LI
TAO LI
As percentages of elderly people rise in many societies, age‐related diseases have become more prevalent than ever. Research interests have been shifting to delaying age‐related diseases by delaying or reversing aging itself. We use metformin as an entry point to talk about the important molecular and genetic longevity‐regulating mechanisms that have been extensively studied with it. Then we review a number of observational studies, animal studies, and clinical trials to reflect the clinical potentials of the mechanisms in lifespan extension, cardiovascular diseases, tumors, and neurodegeneration. Finally, we highlight remaining concerns that are related to metformin and future anti‐aging research.

1 November 2022 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
BCBangwei Chen
Bangwei Chen
LRLei Ruan
Lei Ruan
LYLiuqiao Yang
Liuqiao Yang
YZYucong Zhang
Yucong Zhang
YLYueqi Lu
Yueqi Lu
TLTAO LI
TAO LI
Original Article Machine learning improves risk stratification of coronary heart disease and stroke Bangwei Chen, Liuqiao Yang, Lei Ruan, Yucong Zhang, Yueqi Lu, Yu Sang, Xin Jin, Yong Bai, Cuntai Zhang, Tao Li

18 November 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
YSYing Shan
Ying Shan
YZYucong Zhang
Yucong Zhang
YZYanping Zhao
Yanping Zhao
YLYueqi Lu
Yueqi Lu
BCBangwei Chen
Bangwei Chen
TLTAO LI
TAO LI
Background: Death due to cardiovascular diseases (CVD) increased significantly in China. One possible way to reduce CVD is to identify people at risk and provide targeted intervention. We aim to develop and validate a CVD risk prediction model for Chinese males (CVDMCM) to help clinicians identify those males at risk of CVD and provide targeted intervention.Methods: We conducted a retrospective cohort study of 2,331 Chinese males without CVD at baseline to develop and internally validate the CVDMCM. These participants had a baseline physical examination record (2008–2016) and at least one revisit record by September 2019. With the full cohort, we conducted three models: A model with Framingham CVD risk model predictors; a model with predictors selected by univariate cox proportional hazard model adjusted for age; and a model with predictors selected by LASSO algorithm. Among them, the optimal model, CVDMCM, was obtained based on the Akaike information criterion, the Brier's score, and Harrell's C statistic. Then, CVDMCM, the Framingham CVD risk model, and the Wu's simplified model were all validated and compared. All the validation was carried out by bootstrap resampling strategy (TRIPOD statement type 1b) with the full cohort with 1,000 repetitions.Results: CVDMCM's Harrell's C statistic was 0.769 (95% CI: 0.738–0.799), and D statistic was 4.738 (95% CI: 3.270–6.864). The results of Harrell's C statistic, D statistic and calibration plot demonstrated that CVDMCM outperformed the Framingham CVD model and Wu's simplified model for 4-year CVD risk prediction.Conclusions: We developed and internally validated CVDMCM, which predicted 4-year CVD risk for Chinese males with a better performance than Framingham CVD model and Wu's simplified model. In addition, we developed a web calculator–calCVDrisk for physicians to conveniently generate CVD risk scores and identify those males with a higher risk of CVD.

25 August 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
WZWei Zhang
Wei Zhang
LWLonglong Wang
Longlong Wang
KLKe Liu
Ke Liu
XWXiaofeng Wei
Xiaofeng Wei
KYKai Yang
Kai Yang
XLXiao Liu
Xiao Liu
Motivation: T and B cell receptors (TCRs and BCRs) play a pivotal role in the adaptive immune system by recognizing an enormous variety of external and internal antigens. Understanding these receptors is critical for exploring the process of immunoreaction and exploiting potential applications in immunotherapy and antibody drug design. Although a large number of samples have had their TCR and BCR repertoires sequenced using high-throughput sequencing in recent years, very few databases have been constructed to store these kinds of data. To resolve this issue, we developed a database. Results: We developed a database, the Pan Immune Repertoire Database (PIRD), located in China National GeneBank (CNGBdb), to collect and store annotated TCR and BCR sequencing data, including from Homo sapiens and other species. In addition to data storage, PIRD also provides functions of data visualisation and interactive online analysis. Additionally, a manually curated database of TCRs and BCRs targeting known antigens (TBAdb) was also deposited in PIRD. Availability and Implementation: PIRD can be freely accessed at https://db.cngb.org/pird .

18 March 2024 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
YLYu Liang
Yu Liang
SHSijie He
Sijie He
LYLiuqiao Yang
Liuqiao Yang
TLTAO LI
TAO LI
LZLijian Zhao
Lijian Zhao
CSCong‐Xin Sun
Cong‐Xin Sun
Key Clinical Message: CHARGE syndrome is a rare genetic disorder characterized by several distinct features. The presence of fetal ear abnormalities could be the early indicator of CHARGE syndrome. Subsequent prenatal diagnosis is essential to confirm the disorder. This is significant because the patient may receive genetic counseling and appropriate disposal based on the accurate diagnosis. CHARGE syndrome is a rare genetic disorder with multiple specific clinical features. The prenatal diagnosis is crucial but rarely achieved. We report a fetus with fetal external ear abnormality detected by ultrasound at 22nd week of gestation. Postnatal examination revealed an external ear abnormality, a mild atrial septal defect, and other clinical signs of CHARGE syndrome. A de novo pathogenic nonsense mutation in the CHD7 gene (c.406C > T, p.Q136X in exon 2) was identified to cause the disorder. Our study demonstrated that prenatal diagnosis and genetic testing were recommended to obtain a solid diagnosis of CHARGE syndrome when fetal external ear abnormality was detected by ultrasound examination.

22 May 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
BCBangwei Chen
Bangwei Chen
KWKent Frederick Wirawan
Kent Frederick Wirawan
LLLi Luo
Li Luo
JZJianguo Zhang
Jianguo Zhang
TLTAO LI
TAO LI
Background: Metabolomics enables systematic quantification of small-molecule dynamics underlying cardiovascular pathophysiology, offering mechanistic insights into arterial stiffness. This study aimed to identify the scientific output related to metabolome in arterial stiffness.Methods: This study conducted a bibliometric analysis of publications (2000–March 2025) indexed in the Web of Science Core Collection using VOSviewer and Bibliometrix. Analyses spanned country/institution contributions, authorship networks, journal impact, and keyword/abstract trends.Results: A total of 1,654 original and review papers in English published in 550 different journals by 1,566 institutions were found. Over the past two decades, there has been a significant increase in the number of publications, with seminal work by Maksim et al. demonstrating metabolite associations with arterial stiffness, particularly oxidized low-density lipoprotein. The United States led with 246 articles (14.9%), followed by China (209, 12.6%) and Japan (134, 8.1%). Keyword analysis revealed saturation in advanced vascular aging research (elderly populations, hypertension, stroke), while early vascular aging studies—particularly in youth people—remained underrepresented. A frequency analysis of abstract words identified uric acid, eicosapentaenoic acid, and bile acids as potential metabolic biomarkers. Text-mining identified uric acid, fatty acids and bile acids as priority biomarkers, with unsaturated fatty acids (e.g., eicosapentaenoic acid, arachidonic acid) dominating mechanistic investigations.Conclusion: This first bibliometric profile of arterial stiffness metabolomics highlights fatty acid metabolism as a mature focus, contrasted by emerging opportunities in bile acid and gut microbiota-derived metabolite research. Bridging gaps in early vascular aging cohorts and understudied microbial-host metabolic pathways may unlock novel therapeutic strategies for vascular rejuvenation.